With recent findings that chemerin's receptors are also expressed on malignant tumor cells and that chemerin's expression is often altered in different cancer types, newer studies have focused on chemerin's novel roles in immune surveillance and tumor progression. The gene discussed is RARRES2; the disease is cancer.